Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06260956 · ClinicalTrials.gov registry record · NA

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

A NA study of Food Allergy in Infants and Food Allergy Peanut, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06260956: Recruiting NA study of Food Allergy in Infants and Food Allergy Peanut, sponsored by University of Rochester.

NCT06260956 is a NA study of Food Allergy in Infants and Food Allergy Peanut that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 500 participants, below the 4,880-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06260956, a NA study of Food Allergy in Infants and Food Allergy Peanut, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on maternal consumption or avoidance during pregnancy and breastfeeding.

Primary Outcome

Determine the proportion of high-risk infants who have developed egg or peanut sensitization at four months (prior to introduction of these foods to the infant).

Interventions

  • BEHAVIORAL Consumption
  • BEHAVIORAL Avoidance

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-08-01
Est. Completion 2029-09
Phase NA
University of Rochester

636 total trials

What NCT06260956 shows while recruiting

NCT06260956 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 4,880-participant average among 5 other Food Allergy in Infants trials with a reported enrollment target (90% lower).

The record links to 5 conditions, with Food Allergy in Infants appearing as the primary indexed condition, and to 2 interventions - of which Consumption is the first listed.

NCT06260956 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06260956 about?

NCT06260956 is a clinical study titled "Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg". Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on maternal consumption or av...

What is the current status of trial NCT06260956?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-08-01. Estimated completion is 2029-09.

What conditions does trial NCT06260956 study?

This clinical trial studies the following conditions: Food Allergy in Infants, Food Allergy Peanut, Allergy and Immunology, Peanut and Nut Allergy, Egg Allergy.

What interventions are being tested in trial NCT06260956?

The interventions under investigation include: Consumption (BEHAVIORAL), Avoidance (BEHAVIORAL).

Who is sponsoring clinical trial NCT06260956?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06260956 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Food Allergy in Infants

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06260956, the US trial registry maintained by the National Library of Medicine. NCT06260956 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.